Posted February 21, 2020
Bayer may be on the verge of a deal that would pay in the range of $10 billion for current and future plaintiffs who allege the company’s Roundup herbicide causes cancer, which analysts say would be positive for Bayer. Bayer lawyers have said the company will set aside $8 billion to resolve current cases and reserve $2 billion for future claims, five people with direct knowledge of the negotiations reportedly have said. Read more.